Fu W - Search Results

1

[Explore the mechanism of astragaloside IV-PESV on proliferation, migration, and autophagy of prostate cancer cells based on the PI3K/AKT signaling pathway].

You XJ, Wen Z, Zheng QX, Li QX, Fu W, Li HS, Wang B. You XJ, et al. Among authors: fu w. Zhonghua Nan Ke Xue. 2023 Dec;29(12):963-972. Zhonghua Nan Ke Xue. 2023. PMID: 38639947 Chinese.

2

Application of network pharmacology and molecular docking to elucidate the potential mechanism of Astragalus-Scorpion against prostate cancer.

Wu L, Chen Y, Chen M, Yang Y, Che Z, Li Q, You X, Fu W. Wu L, et al. Among authors: fu w. Andrologia. 2021 Oct;53(9):e14165. doi: 10.1111/and.14165. Epub 2021 Jun 29. Andrologia. 2021. PMID: 34185887

3

Astragalus-Scorpion Drug Pair Inhibits the Development of Prostate Cancer by Regulating GDPD4-2/PI3K/AKT/mTOR Pathway and Autophagy.

You X, Wu Y, Li Q, Sheng W, Zhou Q, Fu W. You X, et al. Among authors: fu w. Front Pharmacol. 2022 Jun 29;13:895696. doi: 10.3389/fphar.2022.895696. eCollection 2022. Front Pharmacol. 2022. PMID: 35847007 Free PMC article.

4

Luteolin induces ferroptosis in prostate cancer cells by promoting TFEB nuclear translocation and increasing ferritinophagy.

Fu W, Xu L, Chen Y, Zhang Z, Chen S, Li Q, You X. Fu W, et al. Prostate. 2024 Feb;84(3):223-236. doi: 10.1002/pros.24642. Epub 2023 Oct 30. Prostate. 2024. PMID: 37904332

5

Astragaloside IV-PESV inhibits prostate cancer tumor growth by restoring gut microbiota and microbial metabolic homeostasis via the AGE-RAGE pathway.

You X, Qiu J, Li Q, Zhang Q, Sheng W, Cao Y, Fu W. You X, et al. Among authors: fu w. BMC Cancer. 2024 Apr 15;24(1):472. doi: 10.1186/s12885-024-12167-z. BMC Cancer. 2024. PMID: 38622523 Free PMC article.

6

Enhancement of anticancer activity of docetaxel by combination with Fuzheng Yiliu decoction in a mouse model of castration-resistant prostate cancer.

Fu W, Hong Z, You X, Din J, Chen B, Zhao B, Yuan G, Li Q. Fu W, et al. Biomed Pharmacother. 2019 Oct;118:109374. doi: 10.1016/j.biopha.2019.109374. Epub 2019 Sep 3. Biomed Pharmacother. 2019. PMID: 31545228 Free article.

7

Quercetin in Tonglong Qibi decoction ameliorates testosterone-induced benign prostatic hyperplasia in rats by regulating Nrf2 signalling pathways and oxidative stress.

Fu W, Chen S, Zhang Z, Chen Y, You X, Li Q. Fu W, et al. Andrologia. 2022 Oct;54(9):e14502. doi: 10.1111/and.14502. Epub 2022 Jun 20. Andrologia. 2022. PMID: 35725022

8

Four types of RNA modification writers predict the prognosis of prostate cancer.

Fu W, Ding J, You X, Li Q, Pei X, Qin G. Fu W, et al. Andrologia. 2022 Nov;54(10):e14552. doi: 10.1111/and.14552. Epub 2022 Aug 3. Andrologia. 2022. PMID: 36177790

9

[Research progress on AMPK activation in nonalcoholic fatty liver disease].

Ye XY, Li TX, Huang ZW, Fu WW, Li Q. Ye XY, et al. Among authors: fu ww. Zhonghua Gan Zang Bing Za Zhi. 2023 Nov 20;31(11):1220-1223. doi: 10.3760/cma.j.cn501113-20231107-00176. Zhonghua Gan Zang Bing Za Zhi. 2023. PMID: 38238958 Chinese.

10

MicroRNA-384 is lowly expressed in human prostate cancer cells and has anti-tumor functions by acting on HOXB7.

Hong Z, Fu W, Wang Q, Zeng Y, Qi L. Hong Z, et al. Among authors: fu w. Biomed Pharmacother. 2019 Jun;114:108822. doi: 10.1016/j.biopha.2019.108822. Epub 2019 Apr 2. Biomed Pharmacother. 2019. PMID: 30951946 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,356 results

Search Page

Filters